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Abstract
Background: To functionally characterize pro-inflammatory and vasoconstrictive properties of cerebrospinal fluid
after aneurysmal subarachnoid hemorrhage (SAH) in vivo and in vitro.
Methods: The cerebrospinal fluid (CSF) of 10 patients suffering from SAH was applied to the transparent skinfold
chamber model in male NMRI mice which allows for in vivo analysis of the microcirculatory response to a
superfusat. Microvascular diameter changes were quantified and the numbers of rolling and sticking leukocytes
were documented using intravital multifluorescence imaging techniques. Furthermore, the pro-inflammatory
properties of CSF were assessed in vitro using a monocyte transendothelial migration assay.
Results: CSF superfusion started to induce significant vasoconstriction on days 4 and 6 after SAH. In parallel, CSF
superfusion induced a microvascular leukocyte recruitment, with a significant number of leukocytes rolling (day 6)
and sticking (days 2-4) to the endothelium. CSF of patients presenting with cerebral edema induced breakdown of
blood vessel integrity in our assay as evidenced by fluorescent marker extravasation. In accordance with leukocyte
activation in vivo, significantly higher in vitro monocyte migration rates were found after SAH.
Conclusion: We functionally characterized inflammatory and vasoactive properties of patients’ CSF after SAH in
vivo and in vitro. This pro-inflammatory milieu in the subarachnoid space might play a pivotal role in the
pathophysiology of early and delayed brain injury as well as vasospasm development following SAH.
Keywords: Subarachnoid hemorrhage, Neuro-inflammation, Cerebral vasospasm, Delayed brain injury, Secondary
brain injury
Background
Cerebral vasospasm following acute aneurysmal subar-
achnoid hemorrhage (SAH) is still one of the most
feared complications of this disastrous disease. Although
recent advances in vasospasm treatment have been
reported [1,2], the pathophysiological mechanisms of
this entity are still under investigation. Within the past
few years, a shift of paradigm with respect to the impact
of cerebral vasospasm has been initiated. The theory
that cerebral vasospasm is the only cause of delayed
brain injury in patients after SAH is being increasingly
questioned and hypotheses of other mechanisms
contributing to early or delayed brain damage are being
discussed [3].
Recently, an activation of inflammatory pathways has
been suggested to be involved in the pathogenesis of
secondary brain injury after SAH [3]. For example, peri-
vascular immune complex accumulation could be
shown around the large conductance vessels as signs for
inflammatory processes [4,5]. The theory of inflamma-
tion to play a role in the pathophysiology of SAH had
been addressed before, suggesting e.g. the arachidonic
acid metabolism with its successive metabolites prosta-
glandins, prostacyclins, thromboxans and leukotrienes to
be potential targets [6-14]. Those changes could be
observed within the first few days after SAH, days before
clinical or diagnostic evidence for vasospasm existed.
Based on this, a relationship between inflammation, and
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SAH has benn discussed [15]. Yet, a functional analysis
of post-SAH CSF might give further insight in the
underlying mechanisms, as well as the time course of
inflammation and vasospasm development, and provide
new therapeutic targets or diagnostic tools.
Therefore, this study was conducted to evaluate
potential vasoconstrictive as well as pro-inflammatory
properties of cerebrospinal fluid (CSF) after SAH. For
this purpose we established an in vivo model in which
vascular reactivity as well as leukocyte endothelial inter-
action could be observed after exposition to post-SAH
CSF. We furthermore applied a cellular in vitro assay to
confirm inflammatory cell attraction by post-SAH CSF.
Methods
Animal experiments were approved by the responsible
ethics committee and conducted according to the regu-
latory guidelines (Regierungspräsidium Karlsruhe). The
withdrawal of post-SAH CSF from the critically ill
patients was approved by the local ethics committee and
conducted throughout the routine CSF sampling (Land-
esamt für Gesundheit und Soziales Berlin). All diagnos-
tic assessments were done on the basis of our
institutional guidelines.
Patient management and assessment of cerebral
vasospasm
For the present study, 10 consecutive patients with severe
SAH (WFNS Grade III or worse, Fisher Grade 3) were
included. The screening was done at the initial presenta-
tion in our institution. The patient characteristics are
displayed in Table 1. All patients received an external
ventricular drainage (EVD) for measurement and therapy
of elevated intracranial pressure (ICP) according to the
clinical guidelines.
Daily bilateral transcranial Doppler ultrasound was
performed for vasospasm screening (blood flow velocity
in the middle cerebral artery (MCA)). When blood flow
velocity increased over 120 cm/min or by more than 50
cm/min within 24 h, Xenon-cCT was scheduled to eval-
uate cerebral blood flow with good spatial resolution
and to assess the hemodynamic relevance of the sus-
pected vasopasm. Furthermore, digital subtraction
angiography (DSA) was performed according to our
standard protocol on days 7-9 after SAH (or earlier in
case of suspected vasospasm). The diagnosis of radiogra-
phical vasospasm was made on the basis of DSA, docu-
menting angiographic arterial narrowing. The diagnosis
of clinical vasospasm was defined by clinical signs of
ischemia and/or vasospasm-associated infarctions in the
CT, as well as a relevant territorial hypoperfusion in Xe-
CT. TCD served as screening method only. In repeated
native CT-scans cerebral infarctions and edema develop-
ment were documented (Figure 1).
As a control group six consecutive patients were
assessed, who were referred to our department for mye-
lography diagnostics of lumbar spine degeneration.
These were considered healthy individuals in terms of
CSF alterations (no high grade spinal canal stenosis).
Although almost all of these patients had medical side
conditions due to their age (arterial hypertension, hyper-
lipidemia, cardiac disease etc.), inflammatory issues were
ruled out by standard laboratory blood sampling.
Transparant chamber preparation
The transparent dorsal skinfold chamber in the mouse is
a model for studying microvascular function under phy-
siological and pathophysiological conditions [16-18].
Recently, this in vivo assay has been used in order to
study pro-inflammatory and vasoactive properties of dif-
ferent molecules which were directly applied to the pre-
paration. Following superfusion/incubation the response
of the microvascular bed to the superfusat was anaylzed
by intravital multiflourescence videomicrcoscopy
[19-21].
Briefly, mature immune competent NMRI mice were
anaesthetized using an intraperitoneally applied mixture
of ketamine and xylazine (7.5 mg ketamine and 2.5 mg
xylazine/100 mg body weight). The hair on the back of
the mice was carefully shaved and chemically epilated.
The dorsal skin was elevated and implanted into two
symmetrically applied titanium frames. In this way the
extended double layer of skin was trapped. The titanium
frames spared an area of 15 mm in diameter in which
the upper skin layer was completely removed and the
Table 1 Patient characteristics.
Vasospasm
Age WFNS Ay location TCD DSA Xe-CT Timepoint
52 4 aCom no yes n.d. 3
74 4 n.a. no no n.d. n.a.
64 4 aCom yes yes no 7
56 4 aCom yes yes yes 7
61 4 aCom yes n.d. yes 9
60 4 aCom yes yes yes 7
50 5 ICA yes n.d. n.d. n.a.
62 4 aCom yes yes yes 9
44 3 pCom yes yes yes 7
42 5 ICA yes yes yes 4
Vasospasm diagnostics were done according to a multimodal concept. The
screening methods were judged positive for: TCD > 200 cm/s; DSA > 50%
narrowing of at least one conductance artery; Xenon CT < 31 ml/100 g/min.
The timepoint of diagnosis establishment is indicated in days after SAH
Abbreviations: aCom anterior communicating artery; pCom posterior
communicating artery; ICA internal carotid artery; TCD transcranial doppler;
DSA digital subtraction angiography; Xe-CT Xenon CT; n.a. not applicable; n.d.
not done; WFNS World Federation of Neurological Surgeons Grading
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Page 2 of 10remaining layer (muscle, subcutaneous tissue and epi-
dermis) was covered with a glass slide.
In this way direct, non-invasive access to the vascula-
ture was gained for the superfusion experiments and
repeated multifluorescence videomicroscopy. For the
experimental protocol only chambers without signs for
bleeding or inflammatory processes (edema, vasodilation
or stasis) were included. In parallel, a catheter was
placed into the jugular vein and was subcutaneously
guided to the dorsal end of the skinfold chamber. This
catheter was used for application of the fluorescent dyes.
Intravital multifluorescence videomicroscopy
For multifluorescence intravital videomicroscopy, the
animals were immobilized in a special mouse restrainer
and fixed upon a table with the titanium frame of the
skinfold chamber. The microscopic examination was
conducted after intravenous application of 1 ml of 5%
Fluorescein Isothiocyanate (FITC)-Dextrane (Mr
150.000; Sigma Chemical Co.; St.Louis, MO). The leuco-
cytes were labelled by 0.1 ml of 0.2% rhodamine 6 G
(Mr = 489; Serva Feinbiochemica GmbH & Co.; Heidel-
berg, Germany). The chamber was observed using a
Zeiss fluorescence stereo-microscope equipped with a
high pressure mercury lamp for epi-illumination (I 2/3
bluefilter 450-490 nm; N2 greenfilter 530-560 nm). By
using two dyes with different emission spectrum the
process of multi-step leukocyte recuitment, i.e. rolling,
sticking, and migration along the endothelium (Rhoda-
mine 6 G) as well as microhaemodynamics (FITC-Dex-
trane) could be evaluated sequentially in the according
observation fields by switching between the filters. A
CCD videocamera mounted on the microscope allowed
for recording of the data for later off-line analysis.
The experimental observation began with a mapping of
the microvascular bed of the preparation for later re-
assessment of the regions of interest. Five arterioles and
five venules (diameter 20-60 μm) were randomly selected
for the documentation. The quantitative analyses of the
microcirculation were performed using a 10× long dis-
tance-objective as well as a 20× immersion-objective with
magnifications of 200× and 400× respectively.
Experimental protocol of in vivo experiments
At the time of initial patient recruitment, the skinfold
chamber was prepared. For each patient and for each
r e s p e c t i v et i m ep o i n to n em o u s ew a sp r e p a r e d( t o t a l
number of animals used for our 16 patients: 64). To
exclude influence of the anaesthesia or the operation
trauma the skinfold chamber experiments did not start
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Figure 1 Study protocol showing standard patient management, timepoints and decision making of imaging as well as the further
processing of post-SAH CSF.
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Page 3 of 10before day 2 after preparation. On days 2, 4, 6 and 8
after occurrence of the SAH, 3-5 ml CSF were harvested
from the EVD of each respective patient. The sample
was centrifuged at 3000/min for 10 min and the super-
natant was withdrawn. All samples were used freshly for
the superfusion experiments, without storage or freez-
ing. One patient who showed signs of bacterial meningi-
tis was excluded from the protocol after diagnosis on
days 4.
First, FITC-Dextran and rhodamine6G were injected i.
v. and a baseline analysis of the microvasculature was
performed. 5 distinct pre-capillary arterioles and post-
capillary venules (20-60 μm) were identified for further
analysis of microhemodynamics and leukocyte/endothe-
lial-interaction. Approximately 30 min later, after
removal of the cover glass, the skinfold chamber was
superfused with 0.5-1 ml of post-SAH- or control CSF
for 10 min. Following superfusion, the chamber was
closed again with a fresh glass cover and the microvas-
culature was visualized using the multifluorescence
videomicroscopic setup. The following microhemody-
namic parameters were documented quantitatively in
the same microvascular segments before and 10, 30, 60,
120, 180 and 240 min after superfusion with CSF:
microvascular diameter, erythrocyte velocity and micro-
vascular permeability, the later of which was defined via
the extent of extravasation of the low-molecular weight
fluorescent marker Rhodamine 6 G. For the evaluation
of the leukocyte flow properties, the leukocyte/endothe-
lial interaction was divided into temporarily (’rolling’)
and permanently adhesive (’sticking’) leucocytes. Rolling
was defined as a passage time of more than 20 s within
the vascular segment (normalized for the diameter). Per-
manent adhesion was documented for sticking leuko-
cytes that remained in one place for longer than 20 s.
The latter were counted as cells per square micrometer.
The area was calculated from the diameter and the
length of the vessel segment (200 μm).
In vitro monocyte migration assay
The membrane surfaces of trans-well chambers (pore
size 5 μm) were coated with 50 μl 0.1% gelatine, were
covered with a layer of human umbilical cord endothe-
lial cells (HUVEC, 80.000/200 μl) and incubated for two
days at 37°C. Staining with crystal violet (1%) permitted
observation of the integrity and the confluence of the
cell layer twice during the incubation time course. In a
second step, 24 h before starting the assay, the human
acute monocytic leukemia cell line THP-1 was incu-
bated with TGF beta-1 (stock solution 5 μg/ml, working
solution 10 ng/ml) and vitamin D (stock solution 50
μmol, working solution 50 nmol) for 24 h. After stimu-
lation these cells yielded a strong expression of CD14+
on their surface, which was verified by FACS analysis,
supposing that they had differentiated into mature
monocytes.
After washing of the HUVEC cell layer, a total num-
ber of 400000/200 μl BSA (0.5%) was applied to each
trans-well chamber and 600 μlo fp o s tS A HC S Fw a s
applied to the respective wells. Again, the CSF samples
of patients undergoing myelography for spinal diagnos-
tics served as controls. After incubation at 37°C for 90
min the assay was stopped and the total number of
CD14+ cells was counted that had transmigrated
through the HUVEC cell layer.
Statistical evaluation
The statistical analysis of arteriolar diameter, rolling and
sticking leukocytes and transmigrated monocytes was
done using univariate ANOVA with posthoc Bonferoni
correction. Edema/Rhodamine Correlation was evaluated
using Wilcoxon ChiSquare test. P-values smaller than
0.05 were considered statistically significant.
Results
Eight patients out of 10 developed hemodynamically,
angiographically or clinically accessible cerebral vasos-
pasm. The diagnosis of cerebral vasospasm was estab-
lished 6.6 ± 2.1 days after the onset of the bleeding.
Post-SAH CSF induces vasoconstriction earlier than the
clinical manifestation of vasospasm
The quantitative analysis of the CSF samples revealed a
significant vasoconstrictive potential of the post-SAH
CSF when compared to control-CSF on days 4 and 6
(Figure 2). The maximum vasoconstriction occurred on
day 4, even before clinical or radiographical diagnosis of
vasospasm. Remarkably, vasoconstrictions of up to 100%
could be repeatedly shown in different arteriolar seg-
ments of preparations superfused with CSF from
patients with vasospasm.
Post-SAH CSF becomes highly pro-inflammatory within 2
days after SAH
Long before clinical manifestation of cerebral vasos-
pasm, analysis of the CSF-samples revealed significant
pro-inflammatory properties of post-SAH CSF. Starting
on day 2 after SAH, an activation of the leukocyte/
endothelial interaction with an increased number of
recruited leukocytes, both rolling and sticking fractions,
could be shown. A significantly increased number of
rolling leukocytes could be shown on day 6, the number
of sticking leukocytes was significantly elevated from
day 2 through day 4 (Figures 3 and 4).
To further assess the pro-inflammatory properties of
post-SAH CSF in vitro we established a THP-1 mono-
cyte transendothelial migration assay. The total number
of CD14+ cells that migrated through the HUVEC cell
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Page 4 of 10layer was significantly elevated after stimulation with
post-SAH CSF during the entire 12 days observation
period after SAH (Figure 5). Again, a significant differ-
ence could be observed much earlier than the clinical
manifestation of cerebral vasospasm, confirming the
results obtained for our in vivo analysis.
Post-SAH CSF of patients with cerebral edema breaks
down microvascular integrity
On days 6 and day 8 after SAH an increase of the
microvascular permeability was documented in terms of
extravasation of the low-molecular fluorescent marker
Rhodamine G6 from the microvasculature. This
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Figure 2 Quantitative analysis of the arteriolar diameter after superfusion of the dorsal skinfold chamber with cerebrospinal fluid
(CSF) of patients after severe subarachnoid haemorrhage. Lower diameters are documented after superfusion with post-SAH CSF.
Significantly lower diameters are documented on days 4 and 6 after SAH. Values are given as means ± standard deviation. * = p < 0.05 vs.
baseline values. N = 10 for post-SAH group (days 2 and 4) and 9 (days 6 and 8), respectively, due to exclusion of one patient’s CSF after
diagnosis of bacterial meningitis. N = 6 for control group.
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Page 5 of 10extravasation could be predominantly observed in the
postcapillary, venular segments of the microcirculation.
A correlation with the clinical course of the individual
patients showed that CSF-induced leakiness of blood
vessels was associated with the development of brain
edema and cerebral infarctions (Table 2).
Discussion
In this study we functionally characterized the pro-
inflammatory and vasoactive milieu in post-SAH CSF in
vivo and in vitro. We described two assays in which the
vasoconstrictive and inflammatory properties of human
CSF could be evaluated in i) a well-established in vivo
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Figure 3 Quantitative analysis of rolling leukocytes after superfusion of the dorsal skinfold chamber with post-SAH CSF showing
significantly higher numbers of rolling leukocytes on day 6. Values are given as means ± standard deviation. * = p < 0.05 vs. baseline
values. N = 10 for post-SAH group (days 2 and 4) and 9 (days 6 and 8), respectively, due to exclusion of one patient’s CSF after diagnosis of
bacterial meningitis. N = 6 for control group.
Schneider et al. Journal of Neuroinflammation 2012, 9:28
http://www.jneuroinflammation.com/content/9/1/28
Page 6 of 10animal model for microcirculatory studies and ii) an in
vitro monocyte transendothelial migration assay. This
experimental setup provided evidence for significant
early vasoconstrictive and inflammatory characteristics
of human post-SAH CSF. This was displayed by a signif-
icant arteriolar vasoconstriction and intravascular
leukocyte recruitment in the in vivo assay, that preceded
the diagnosis of cerebral vasospasm in our patients. The
increased chemotaxis of THP-1 monocytes in the in
vitro assay documented upregulated trans-endothelial
migration properties of inflammatory cells upon stimu-
lation with post-SAH CSF.
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Figure 4 Quantitative analysis of sticking leukocytes after superfusion of the dorsal skinfold chamber with post-SAH CSF showing
significantly higher numbers of sticking leukocytes on days 2 and 4. Values are given as means ± standard deviation. * = p < 0.05 vs.
baseline values. N = 10 for post-SAH group (days 2 and 4) and 9 (days 6 and 8), respectively, due to exclusion of one patient’s CSF after
diagnosis of bacterial meningitis. N = 6 for control group.
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brain injury, development of cerebral vasospasm and
delayed brain injury after SAH has been more and more
discussed within the past years [3,6-15,22]. Hypotheses
exist that inflammatory processes also occur in the walls
of ruptured aneurysms and might therefore facilitate or
lead to aneurysmal bleeding [23-25]. However, the med-
iation of these inflammatory processes still remains
unclear. Clinically relevant therapeutic targets have not
yet been established.
Supposing that post-SAH CSF has the capability to
attract a significant number of inflammatory cells from
the circulation and pool them in the subarachnoid space,
an inflammatory milieu might be elicited along the blood
vessels and in the basal cisterns. This inflammatory envir-
onment might initiate or contribute to cerebral vasos-
pasm. As a possible mediator for vasoconstrictive and
inflammatory activity interleukin-6 has already been
discussed. An upregulation of this inflammatory cytokine
has been observed extraparenchymally in the CSF, but
also in the brain parenchyma itself (microdialysis) in
patients after SAH [26]. In addition, our group has
demonstrated that monocytes within the subarachnoid
space may be the source of vascoactive/vasoconstrictive
mediators such as endothelin-1 [27]. To further enlight
the underlying mechanisms, the two described assays add
favourably to the existing literature, which mostly
focused on histological, molecular or ex vivo analysis of
inflammatory changes following SAH [6-14].
Our study has several limitations. Due to the small
number of patients, a correlation analysis of the detected
CSF changes with the development of cerebral vasos-
pasm or secondary brain injury could not be performed.
Nevertheless, our data were suggestive for a time rela-
tionship between the occurrence of vasoconstriction and
leukocyte activation in the assays and the clinical onset
of vasospasm. Cerebral vasospasm was diagnosed in our
patients between days 3 and 9 by TCD, Xe-CT and/or
DSA (mean 6.6 ± 2.1 days), which is well in accordance
with the known time course of vasospasm in man. Yet,
despite the tight diagnostic regime, we cannot exclude,
that we missed an earlier development of cerebral vasos-
pasm in our patients and the observed CSF alterations
were an epiphenomenon. Furthermore, the evaluation of
the dorsal skinfold chamber elicited high standard devia-
tions, due to a high interindividual variability, especially
Figure 5 The monocyte transendothelial migration assay showed significantly higher numbers of CD14+ monocyte cells that had
migrated through the HUVEC cell layer after stimulation with post-SAH CSF when compared to stimulation with control CSF.*=p <
0.05 vs control CSF # = p < 0.05 vs days 1-3 and days 4-6. N = 10 for post-SAH group (days 1-3) and 9 (days 4-12), respectively, due to exclusion
of one patient’s CSF after diagnosis of bacterial meningitis. N = 6 for control group.
Table 2 An increased extravasation of Rhodamine 6 G
was documented in the preparations’ microvasculature
after superfusion with CSF of patients in whom edema or
stroke were present at the according time points
Extravasation of Rhodamine 6G
Edema/Stroke positive negative
present 5 2
absent 0 3 p < 0.05
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Page 8 of 10in the leukocyte/endothelial interaction. We therefore
faced the following statistical problems. 1. Irregularities
i nt h ed a t ac u r v e sg a v ea ni m p r e s s i o no fa nu n s t e a d y
response to the superfusion. 2. Alpha as well as beta
errors might be underestimated.
Of 10 patients eight developed cerebral vasospasm,
which seems much. Yet, all of the patients, included in
our study suffered from severe SAH (WFNS III or
worse, Fisher Grade 3). Thus, the observed high inci-
dence of morphological vasospasm is within the
reported range. Furthermore, we used a tight regimen of
multiple testing methods, not to miss out on the occur-
rence of cerebral vasospasm.
Conclusion
The present study supports the existing theory that
inflammatory mechanisms can contribute to secondary
brain injury after SAH. We could functionally demon-
strate an inflammatory millieu in post-SAH CSF in vivo
and in vitro. The detected inflammatory changes were
accompanied by microvascular diameter changes, and
preceded the clinical diagnosis of cerebral vasospasm in
our patient population.
Acknowledgements
We thank the personnel on our intensive care unit for their support.
Author details
1Department of Neurosurgery, Charité Universitaetsmedizin, Augustenburger
Platz 1, 13353 Berlin, Germany.
2Center for Stroke Research Berlin, Charité
Universitaetsmedizin, Berlin, Germany.
Authors’ contributions
UCS: conduction of the experiments, analysis and interpretation of the data,
composition of the manuscript (full responsibility for the content). JS:
conduction of experiments, interpretation of the data, involved in
composition of the manuscript (partial responsibility for the content). NH:
establishment of the technical procedures, conduction of experiments,
review of the manuscript (partial responsibility for the content). PH:
substantial contributions to concept and design, conduction of experiments,
interpretation of data (partial responsibility for the content). PV: conception
and design, interpretation of the data, revision and approval of the
manuscript (full responsibility for the content). All authors read and
approved the final manuscript.
Competing interests
Source of Funding of the project: Centre for Stroke Research, Berlin,
Germany. Otherwise, none of the authors has any financial or non-financial
competing interests concerning the current study.
Received: 29 August 2011 Accepted: 8 February 2012
Published: 8 February 2012
References
1. Barth M, Capelle H-H, Weidauer S, Weiss C, Münch E, Thomé C, Luecke T,
Schmiedek P, Kasuya H, Vajkoczy P: Effect of nicardipine prolonged-
release implants on cerebral vasospasm and clinical outcome after
severe aneurysmal subarachnoid hemorrhage: a prospective,
randomized, double-blind phase IIa study. Stroke 2007, 38:330-336.
2. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thomé C, Ringel F, Breu V,
Schmiedek P: Clazosentan (AXV-034343), a selective endothelin A
receptor antagonist, in the prevention of cerebral vasospasm following
severe aneurysmal subarachnoid hemorrhage: results of a randomized,
double-blind, placebo-controlled, multicenter phase IIa study.
J Neurosurg 2005, 103:9-17.
3. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH: Cerebral
vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci 2007,
28:252-256.
4. Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M,
Shibuya M, Yoshida J: Interleukin-6 and development of vasospasm after
subarachnoid haemorrhage. Acta Neurochir (Wien) 1998, 140:943-951.
5. Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, Lee KS:
Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the
cerebrospinal fluid of patients after subarachnoid hemorrhage.
J Neurosurg 1998, 89:559-567.
6. Hagen AA, Gerber JN, Sweeley CC, White RP, Robertson JT: Levels and
disappearance of prostaglandin F2a in cerebral spinal fluid: a clinical
and experimental study. Stroke 1977, 8:672-675.
7. Boullin DJ, Bunting S, Blaso WP, Hunt TM, Moncada S: Responses of
human and baboon arteries to prostaglandin endoperoxides and
biologically generated and synthetic prostacyclin: their relevance to
cerebral arterial spasm in man. Br J Clin Pharmacol 1979, 7:139-147.
8. Brandt L, Ljunggren B, Andersson KE, Hindfelt B, Uski T: Prostaglandin
metabolism and prostacyclin in cerebral vasospasm. Gen Pharmac 1982,
14:141-143.
9. Rodriguez-y-Baena R, Gaetani P, Folco G, Vigano T, Paoletti P: Arachidonate
metabolites and vasospasm after subarachnoid hemorrhage. Neurol Res
1986, 8:25-32.
10. Rodriguez-y-Baena R, Gaetani P, Grignani G, Pacchiarini L: Effect of
nimodipine on arachidonic acid metabolites after subarachnoid
hemorrhage. Acta Neurol Scand 1987, 76:267-271.
11. Paoletti P, Gaetani P, Grignain G, Pacchiarini L, Silvani V, Rodriguez-y-
Baena R: CSF leukotriene C4 following subarachnoid hemorrhage.
J Neurosurg 1988, 69:488-493.
12. Rodriguez-y-Baena R, Gaetani P, Paoletti P: A study on cisternal CSF levels
of arachidonic acid metabolites after aneurysmal subarachnoid
hemorrhage. J Neurol Sci 1988, 84:329-335.
13. Chehrazi BB, Giri S, Joy RM: Prostaglandins and vasoactive amins in
cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke
1989, 20:217-224.
14. Minami N, Tani E, Yokota Y, Maeda Y, Yamaura I: Immunohistochemistry of
leukotriene C4 in experimental cerebral vasospasm. Acta Neuropathol
1991, 81:401-407.
15. Pradilla G, Chaichana KL, Hoang S, Huang J, Tamargo RJ: Inflammation and
cerebral vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am
2010, 21:365-379.
16. Vajkoczy P, Menger MD, Simpson E, Messmer K: Angiogenesis and
vascularization of murine pancreatic islet isografts. Transplantation 1995,
60:123-127.
17. Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M,
Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong TA, Strawn LM, Sun L,
Tang C, Hawtin R, Tang F, Shenoy N, Hirth KP, McMahon G, Cherrington :
SU6668 is a potent antiangiogenic and antitumor agent that induces
regression of established tumors. Cancer Res 2000, 60:4152-4160.
18. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD: Combined
inhibition of vascular endothelial growth factor (VEGF), fibroblast growth
factor and platelet-derived growth factor, but not inhibition of VEGF
alone, effectively suppresses angiogenesis and vessel maturation in
endometriotic lesions. Hum Reprod 2006, 21:262-268.
19. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G,
Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M,
Preissner KT, Vajkoczy P, Augustin HG: Angiopoietin-2 sensitizes
endothelial cells to TNF-alpha and has a crucial role in the induction of
inflammation. Nat Med 2006, 12:235-239.
20. Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L,
Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA,
Ballantyne CM, Constant SL, Aird WC, Papayannopoulou T, Gahmberg CG,
Udey MC, Vajkoczy P, Quertermous T, Dimmeler S, Weber C, Chavakis T:
Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits
inflammatory cell recruitment. Science 2008, 322:1101-1104.
21. Rasi K, Piuhola J, Czabanka M, Sormunen R, Ilves M, Leskinen H, Rysä J,
Kerkelä R, Janmey P, Heljasvaara R, Peuhkurinen K, Vuolteenaho O,
Ruskoaho H, Vajkoczy P, Pihlajaniemi T, Eklund L: Collagen XV is necessary
Schneider et al. Journal of Neuroinflammation 2012, 9:28
http://www.jneuroinflammation.com/content/9/1/28
Page 9 of 10for modeling of the extracellular matrix and its deficiency predisposes
to cardiomyopathy. Circ Res 2010, 107:1241-1252.
22. Ostrowski RP, Colohan AR, Zhang JH: Molecular mechanisms of early
brain injury after subarachnoid hemorrhage. Neurol Res 2006, 28:399-414.
23. Tulamo R, Frösen J, Junnikkala S, Paetau A, Pitkäniemi J, Kangasniemi M,
Niemelä M, Jääskeläinen J, Jokitalo E, Karatas A, Hernesniemi J, Meri S:
Complement activation associates with saccular cerebral artery
aneurysm wall degeneration and rupture. Neurosurgery 2006,
59:1069-1076, discussion 1076-7.
24. Frösen J, Piippo A, Paetau A, Kangasniemi M, Niemelä M, Hernesniemi J,
Jääskeläinen J: Remodeling of saccular cerebral artery aneurysm wall is
associated with rupture: histological analysis of 24 unruptured and 42
ruptured cases. Stroke 2004, 35:2287-2293.
25. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R: Structural
fragility and inflammatory response of ruptured cerebral aneurysms. A
comparative study between ruptured and unruptured cerebral
aneurysms. Stroke 1999, 30:1396-1401.
26. Sarrafzadeh A, Schlenk F, Gericke C, Vajkoczy P: Relevance of cerebral
interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care
2010, 13:339-346.
27. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schütt S,
Fritzinger M, Horn P, Vajkoczy P, Wendel-Wellner M, Ragoschke A, Kuehl S,
Brunner J, Schürer L, Schmiedeck P, Hennerici M: Endothelin-1 in
subarachnoid hemorrhage: an acute-phase reactant produced by
cerebrospinal fluid leukocytes. Stroke 2000, 31:2971-2975.
doi:10.1186/1742-2094-9-28
Cite this article as: Schneider et al.: Functional analysis of Pro-
inflammatory properties within the cerebrospinal fluid after
subarachnoid hemorrhage in vivo and in vitro. Journal of
Neuroinflammation 2012 9:28.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Schneider et al. Journal of Neuroinflammation 2012, 9:28
http://www.jneuroinflammation.com/content/9/1/28
Page 10 of 10